BMB Reports : eISSN 1976-670X

Cited by CrossRef (15)

  1. Hee-Young Jeon, Cheol Gyu Park, Seok Won Ham, Sang-Hun Choi, Seon Yong Lee, Jung Yun Kim, Sunyoung Seo, Xiong Jin, Jun-Kyum Kim, Kiyoung Eun, Eun-Jung Kim, Hyunggee Kim. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence. Journal of Medicinal Food 2017;20:838
  2. Stefano Falone, Silvano Santini, Valeria Cordone, Giovanna Di Emidio, Carla Tatone, Marisa Cacchio, Fernanda Amicarelli. Extremely Low-Frequency Magnetic Fields and Redox-Responsive Pathways Linked to Cancer Drug Resistance: Insights from Co-Exposure-Based In Vitro Studies. Front. Public Health 2018;6
  3. Marta Prieto-Vila, Ryou-u Takahashi, Wataru Usuba, Isaku Kohama, Takahiro Ochiya. Drug Resistance Driven by Cancer Stem Cells and Their Niche. IJMS 2017;18:2574
  4. Priya Chatterji, Julie Douchin, Véronique Giroux. Demystifying the Differences Between Tumor-Initiating Cells and Cancer Stem Cells in Colon Cancer. Curr Colorectal Cancer Rep 2018;14:242
  5. Lin Ma, Lan Wang, Yating Shan, Muhammad Nafees, Elshoura Ihab, Ruhui Zhang, Fangjun Wang, Wu Yin, Gianpaolo Papaccio. Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma. PLoS ONE 2017;12:e0188665
  6. Elize Wolmarans, Sonja C. Boy, Sulette Nel, Anne E. Mercier, Michael Sean Pepper. Stem Cells: Biology and Engineering. 2017.
  7. Petra Gener, Joaquin Seras-Franzoso, Patricia González Callejo, Fernanda Andrade, Diana Rafael, Francesc Martínez, Sara Montero, Diego Arango, Joan Sayós, Ibane Abasolo, Simó Schwartz. Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells. Stem Cells International 2018;2018:1
  8. Cong-Cong Wu, Zhi-Jun Sun. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma. Pathology - Research and Practice 2019
  9. Justin D. Lathia, Huiping Liu. Overview of Cancer Stem Cells and Stemness for Community Oncologists. Targ Oncol 2017;12:387
  10. Muhammad Saif, E. I. Ager, Penelope Field, K. J. Lilischkis. The role of cancer stem cells and the therapeutic potential of TRX-E-002-1 in ovarian cancer. Expert Opinion on Orphan Drugs 2018;6:465
  11. Pavani Koka, Reddy Sailaja Mundre, Rohini Rangarajan, Yamini Chandramohan, Raghunandha Kumar Subramanian, Anuradha Dhanasekaran. Uncoupling Warburg effect and stemness in CD133+ve cancer stem cells from Saos-2 (osteosarcoma) cell line under hypoxia. Mol Biol Rep 2018;45:1653
  12. Kevin Dzobo, Naseeha Hassen, Dimakatso Senthebane, Nicholas Thomford, Arielle Rowe, Hendrina Shipanga, Ambroise Wonkam, M. Parker, Shaheen Mowla, Collet Dandara. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?. Molecules 2018;23:930
  13. Kevin Dzobo, Dimakatso Alice Senthebane, Nicholas Ekow Thomford, Arielle Rowe, Collet Dandara, M. Iqbal Parker. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development. OMICS: A Journal of Integrative Biology 2018;22:17
  14. Monica Marzagalli, Roberta Manuela Moretti, Elio Messi, Marina Montagnani Marelli, Fabrizio Fontana, Alessia Anastasia, Maria Rosa Bani, Giangiacomo Beretta, Patrizia Limonta. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol. Sci Rep 2018;8
  15. Marina Montagnani Marelli, Monica Marzagalli, Fabrizio Fontana, Michela Raimondi, Roberta Manuela Moretti, Patrizia Limonta. Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets. J Cell Physiol 2019;234:1147